Corcept Therapeutics | Vertriebs- Und Verwaltungskosten



Selling And Administration Expenses Veränderung Datum
Acadia Pharmaceuticals USD 123.66M 2.71M 2025-06
Alaunos Therapeutics USD 845K 162K 2024-12
ANI Pharmaceuticals USD 81.77M 5.24M 2025-06
Ardelyx USD 76.07M 11.1M 2024-12
Aurora Cannabis CAD 38.18M 2.05M 2024-12
BioMarin Pharmaceutical USD 232.28M 26.16M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Canopy Growth CAD 40.62M 308K 2024-12
Corcept Therapeutics USD 103.85M 13.19M 2025-06
Eli Lilly USD 2.75B 390.8M 2025-06
J&J USD 5.89B 777M 2025-06
Knight Therapeutics CAD 25.48M 119K 2024-09
Merck USD 2.63B 104M 2025-06
Novartis USD 3.44B 384M 2025-06
Novartis USD 3.5B 368M 2024-12
Pacira USD 77.19M 9.58M 2025-06
Pfizer USD 3.42B 406M 2025-06
Supernus Pharmaceuticals USD 62.22M 27.72M 2025-06
TG Therapeutics USD 12.04M 38.29M 2025-06


Corcept Therapeutics Vertriebs- Und Verwaltungskosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.